Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D

Clinical trial NCT06439056 · COMPLETED

Trial details

NCT number: NCT06439056
Sponsor: Nanexa AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-05-27
Primary completion: 2025-07-18
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.